Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Sham-controlled Crossover Study Using Photoneuromodulation to Treatment the Negative Symptoms of Schizophrenia.

NCT05339347 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT05339347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05339347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Sham-controlled Crossover Study Using Photoneuromodulation to Treatment the Negative Symptoms of Schizophrenia.
Lead sponsor
University of Sao Paulo
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2021
Completion date
March 11, 2022
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia